Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Nighthawk Biosciences Inc | NHWK | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4135 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4135 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.258 - 0.885 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.4135 | USD |
Nighthawk Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 62.08M | 26.08M | - | 7M | -45.22M | -1.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nighthawk Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/03/2024 | 15:00 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 5/03/2024 | 06:18 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 5/02/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/30/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/29/2024 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/22/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/01/2024 | 15:52 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
| 3/19/2024 | 07:30 | GlobeNewswire Inc. | Scorpius Holdings Awarded Contract in Excess of $1 Million.. |
| 3/14/2024 | 07:30 | GlobeNewswire Inc. | Scorpius Holdings Accepted as a Member of the US.. |
| 3/13/2024 | 05:17 | Edgar (US Regulatory) | Form 8-A12B/A - Registration of securities [Section 12(b)]:.. |
| 3/13/2024 | 05:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/12/2024 | 16:00 | GlobeNewswire Inc. | Scorpius Holdings, Inc. Announces Closing of Public Offering |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NHWK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.34 | 0.55 | 0.258 | 0.363031 | 207,416 | 0.0735 | 21.62% |
| 1 Year | 0.6407 | 0.885 | 0.258 | 0.5378948 | 120,371 | -0.2272 | -35.46% |
| 3 Years | 2.50 | 3.42 | 0.258 | 1.47 | 119,765 | -2.09 | -83.46% |
| 5 Years | 2.50 | 3.42 | 0.258 | 1.47 | 119,765 | -2.09 | -83.46% |
Nighthawk Biosciences Description
| NightHawk Biosciences is a fully integrated biopharmaceutical company focused on the development of new drugs from discovery through commercialization. The Company leverages its integrated ecosystem of subsidiaries to accelerate the creation and manufacture of novel therapies that arm the immune system, breaking through barriers that prolong traditional drug development. This empowers us to bring our ideas to life with efficient control, superior quality, and uncharacteristic agility. |
